Remove 2002 Remove Public Health Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

It will also facilitate cross-border circulation of these critical health therapies as well as cross-border cooperation between public health authorities. This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

These are requirements of the Therapeutic Goods (Medical Devices) Regulations 2002. The MDVP pilot aims to identify areas that may require improvement in order to ensure appropriate monitoring and communications are in place to support the ongoing safety of medical devices available to the Australian public.

FDA 52